Certara Investor Presentation Deck
Biosimulation TAM Segmentation
Certara Solutions
(illustrative examples)
Biosimulation Software
~50%
Scientists at global pharmaceutical companies,
mid-tier pharma, biotechs and CROS
Drug Discovery
~45%
Quantitative Systems
Pharmacology (QSP)
o Immuno-oncology QSP
o Immunogenicity QSP
• Discovery Informatics
o D360 Software
© Copyright 2022 Certara, Inc. All rights reserved.
●
●
●
Biosimulation TAM
$2.8B
Drug Development
~55%
PBPK¹
o Simcyp Simulator
PK/PD²
o Phoenix Software
Model-based meta-analysis
o CODEX Databases
1 Physiologically-based pharmacokinetic (PBPK)
2 Pharmacokinetic/pharmacodynamic (PK/PD)
Drug
Discovery
~20%
QSP
Consulting
●
●
Biosimulation Services
~50%
Drug R&D programs
Drug Development
~80%
PBPK Consulting
PK/PD analysis
Model-based meta-analysis
12
CERTARAView entire presentation